Legal status · Canada
Is Domagrozumab legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Domagrozumab is not an approved medicine in Canada; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 3 human studies are cited on its profile.
Domagrozumab in Canada at a glance
| Classification | Not approved |
|---|---|
| Health Canada approval status | Not approved by Health Canada |
| Human studies cited | 3 of 3 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Domagrozumab profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
No product containing Domagrozumab is approved by Health Canada for any use in Canada, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Canada. This page is general information, not legal advice.
What Domagrozumab is
A properly powered phase 2 in 120 boys with Duchenne muscular dystrophy. The primary endpoint missed by 0.27 seconds at p equals 0.94, no secondary clinical endpoint differed, and both trials were terminated.
This is the most definitive negative result in the myostatin field, and it is definitive because the trial was well built. 120 ambulatory boys with Duchenne muscular dystrophy, 80 on ascending doses up to 40 mg/kg and 40 on placebo, two 48-week periods, with a functional primary endpoint and an open-label extension.
Mechanism: A humanised monoclonal antibody against myostatin, same target and pathway as stamulumab and landogrozumab. Dosed intravenously in this programme at 5, 20 and 40 mg/kg, higher than the earlier antibodies, on the reasoning that the earlier failures reflected insufficient potency.
Regulatory history: Never approved. Both phase 2 trials carry status TERMINATED on ClinicalTrials.gov.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Domagrozumab at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Domagrozumab in other countries
Frequently asked questions
Is Domagrozumab legal in Canada?
No. Domagrozumab is not an approved medicine in Canada; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 3 human studies are cited on its profile.
Can I buy Domagrozumab in Canada?
No approved product exists to buy. In Canada Domagrozumab is classified as "Not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Domagrozumab Health Canada approved?
No. In Canada Domagrozumab is classified as "Not approved", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Never approved. Both phase 2 trials carry status TERMINATED on ClinicalTrials.gov.. On the evidence, 3 human studies are cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Domagrozumab live on its compound profile.
Domagrozumab profileThis page is general information about the regulatory status of Domagrozumab in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.